Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01818557 · ClinicalTrials.gov registry record · NA
Frequency of Blood Glucose Monitoring in Patients With Gestational Diabetes
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 293
- Enrollment target
NCT01818557 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 293 participants.
The verdict
NCT01818557, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 293 participants
- Enrollment target
Study Summary
The incidence of gestational diabetes mellitus (GDM) is increasing. GDM requires patients to test their blood glucose at least four times daily. The investigators propose to prospectively evaluate blood glucose testing done every day compared to every other day. The primary goal is to establish the most cost-effective modality while still being able to detect patients who require therapy in a timely fashion. The investigators plan to evaluate this new management scheme utilizing a non-inferiority trial design. The investigators primary research question is the following: When managing patients with GDM, is every other day blood glucose testing non-inferior compared to every day blood glucose testing, as measured by the difference of less than 5% in birth weight?
Interventions
- BEHAVIORAL Blood glucose testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 293 participants |
| Start Date | 2013-05 |
| Est. Completion | 2016-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01818557
The ClinicalTrials.gov registry entry for NCT01818557 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 293 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood glucose testing is the first listed.
NCT01818557 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01818557 about?
NCT01818557 is a clinical study titled "Frequency of Blood Glucose Monitoring in Patients With Gestational Diabetes". The incidence of gestational diabetes mellitus (GDM) is increasing. GDM requires patients to test their blood glucose at least four times daily. The investigators propose to prospectively evaluate blood glucose testing done every day compared to every other day. The primary goal is to establish the ...
What is the current status of trial NCT01818557?
This trial is currently completed. It is a NA study. The enrollment target is 293 participants. The study started on 2013-05. Estimated completion is 2016-10.
What interventions are being tested in trial NCT01818557?
The interventions under investigation include: Blood glucose testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT01818557?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.